Previous 10 | Next 10 |
AUSTIN, Texas, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” “MTEM” or “the Company”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted bi...
AUSTIN, Texas, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of the company’s proprietary engineered toxin b...
The following healthcare companies have filed for mixed shelf offerings: More news on: Kura Oncology, Inc., Alphatec Holdings, Inc., Dynavax Technologies Corporation, Healthcare stocks news, , Read more ...
Molecular Templates (NASDAQ: MTEM ) : Q2 GAAP EPS of -$0.68 misses by $0.32 . More news on: Molecular Templates, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Molecular Templates (NASDAQ: MTEM ) has raised ~$43M through its At-the-Market facility, with participation from Consonance Capital Management. More news on: Molecular Templates, Inc., Healthcare stocks news, , Read more ...
AUSTIN, Texas, July 20, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” “MTEM” or the “Company”), a clinical-stage biopharmaceutical company focused on the discovery and development of the Company’...
Update Provided Phase I Study of MT-5111 in HER2-positive Cancers Conference Call and Webcast to Discuss AACR Posters on June 25th at 10:30am Eastern Time AUSTIN, Texas, June 22, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,”...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
Shares of Molecular Templates ( MTEM ) have risen by 157% since my 2018 recommendation and by 127% since my September 2019 update . In the latter, I highlighted an agreement with Takeda to develop CD38-targeted engineered toxin bodies (ETBs) and potential advantages over approved drug Darza...
Molecular Templates (NASDAQ: MTEM ) files for 9,440,392 share offering by selling shareholders. More news on: Molecular Templates, Inc., , Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Molecular Templates Inc. Company Name:
MTEM Stock Symbol:
NASDAQ Market:
Molecular Templates Inc. Website:
AUSTIN, Texas, May 15, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineere...